Information Sharing AgreementSource • May 8th, 2017
Contract Type FiledMay 8th, 2017
Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB® in JapanSource • February 13th, 2019
Contract Type FiledFebruary 13th, 2019Gosselies, Belgium, 22 September 2017, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces it has signed an exclusive, royalty-bearing license agreement with one of Japan's leading industrial companies, Asahi Kasei Corporation (Tokyo: 3407). The license agreement covers the development and commercialisation of Bone Therapeutics' autologous bone cell therapy product, PREOB®, in Japan.